AI Verdict
HRMY has stronger fundamentals based on our AI analysis.
HRMY vs HR Fundamental Comparison
| Metric | HRMY | HR |
|---|---|---|
| Revenue | $868.5M | $1.2B |
| Net Income | $158.7M | $-246.1M |
| Net Margin | 18.3% | -20.8% |
| ROE | 18.2% | -5.3% |
| ROA | 12.5% | -2.7% |
| Current Ratio | 3.60x | N/A |
| Debt/Equity | 0.19x | 0.85x |
| EPS | $2.71 | $-0.71 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HRMY vs HR: Frequently Asked Questions
Is HRMY or HR a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HRMY has stronger fundamentals. HRMY is rated BUY (78% confidence) while HR is rated HOLD (72% confidence). This is not investment advice.
How does HRMY compare to HR fundamentally?
Harmony Biosciences Holdings, Inc. has ROE of 18.2% vs Healthcare Realty Trust Inc's -5.3%. Net margins are 18.3% vs -20.8% respectively.
Which stock pays higher dividends, HRMY or HR?
HRMY has a dividend yield of N/A or no dividend while HR has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HRMY or HR for long term?
For long-term investing, consider that HRMY has BUY rating with 78% confidence, while HR has HOLD rating with 72% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HRMY vs HR?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HRMY vs HR, the AI consensus favors HRMY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.